TARS
Tarsus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$78.09
−1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 51.79x
- P/E 2028E
- 18.60x
- P/S forward
- 4.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.54x
- Price / sales
- 6.03x
- Price / cash flow
- 45.85x
Enterprise value
- Enterprise value
- $3.3B
- EV / sales
- 5.43x
- EV / EBITDA
- -93.51x
- EV / EBIT
- -67.85x
- Market cap
- $3.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026